Navigation Links
Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
Date:8/16/2011

edicine and an author on the study. "Results from this subgroup analysis show that more than one in four patients with CDAD were also taking concomitant antibiotics for other infections and that concomitant antibiotic therapy can significantly compromise CDAD treatment. The results also suggest that DIFICID may help blunt the effect of concomitant antibiotics on response to CDAD treatment and that continued investigation of the impact of concomitant antibiotic use in this patient population is warranted."

Effect of Concomitant Antibiotic Use on Clinical Outcomes

Among patients analyzed in the study, the use of concomitant antibiotics compromised response to CDAD therapy. For the combined DIFICID and vancomycin treatment groups, CDAD patients who received concomitant antibiotics had clinical cure rates of 84.4%, compared to cure rates of 92.6% among patients who did not (p<0.001), and experienced a median extended time to resolution of diarrhea of 97 hours compared to 54 hours in patients who did not receive additional antibiotics (p<0.001).  Global cure was observed in 74.7% of patients who did not receive concomitant antibiotics compared to 65.8% of patients receiving concomitants antibiotics at any time during the study (p= 0.005). Use of concomitant antibiotics tended to increase the rate of recurrence but did not reach significance.

Effect of DIFICID vs. Vancomycin with Concomitant Antibiotics

In the absence of concomitant antibiotic use, DIFICID and vancomycin were similar in achievement of clinical cure by the end of treatment (92.3% vs. 92.8%; p= 0.80). However, when patients received one or more antibiotics concurrently with study drug, DIFICID was superior to vancomycin in achieving clinical cure (90.0% vs. 79.4% p = 0.04). When patients received no additional antibiotics at any time during the study, the global cure rate was 80.8% for DIFICID patients and 69.1% for vancomycin patients(p < 0.001). 
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  Rebiotix Inc. announced this morning that results of ... RBX2660 (microbiota suspension) will be presented in two posters and ... Philadelphia from October 8-12. ... session on Thursday, October 9, 2014: Poster: RBX2660 ... Interim Analysis of the PUNCH-CD Phase 2 Safety Study ...
(Date:9/17/2014)... 17, 2014  Bayer HealthCare will present data on ... th Annual Meeting, which takes place September 18-20 ... which will be shared through poster presentations, showcase Bayer,s ... Data will be presented in a scientific forum. ... in hemophilia A patients, Bayer is maintaining its commitment ...
(Date:9/17/2014)... September 17, 2014 According to ... Component (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU), by ... Wellness), and by Geography - Global Forecast to 2020", ... market is expected to reach $56.50 Billion by 2020, ... 2020. Browse 235 market data Tables and ...
Breaking Medicine Technology:PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4
... (Nasdaq: ENDP ) today announced that it will present ... 2011 at 3:45 p.m. ET.  Dr. Ivan Gergel executive vice president ... programs. The presentation will be webcast live and can ... investors section.   About Endo ...
... nation,s leading retail pharmacy, brings its "To Your Health" ... Texas. The program will provide free preventive health screenings ... through November as a way to help citizens determine ... a path to better health. (Logo: ...
Cached Medicine Technology:CVS/pharmacy Debuts the 'To Your Health' Program in Dallas and Fort Worth Texas, Bringing More Than 80 Free Health Screening Events to the Community 2CVS/pharmacy Debuts the 'To Your Health' Program in Dallas and Fort Worth Texas, Bringing More Than 80 Free Health Screening Events to the Community 3
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 ... Order; Motion to Compel Discovery; Motion for Protective ... that have been the subject of multiple telephone ... development of a “new process for the collection, ... from Plaintiffs during mesh revision or removal procedures,” ...
(Date:9/18/2014)... 2014) Cardiovascular disease is the leading causes of ... role in accelerating its progression. Medical practitioners have ... cholesterol-carrying lipoproteins such as small dense lipoproteins (sdLDL), ... out today in the Journal of Cardiovascular ... be more effective among prediabetic patients than patients ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 On August ... “Stinger” Glenn with the Distinguished Service Award for ... attendees at the 2014 National Basketball Retired Players Association ... First drafted by the Chicago Bulls in 1977, Glenn ... the New York Knicks, the Atlanta Hawks, and the ...
(Date:9/18/2014)... One Week Kitchens will have their award ... beginning this Saturday. Their display will be inside the Industrial ... the products and design services that are offered at One ... fair-goers to see. This display won ‘Most Beautiful Display’ at ... and really is something to see. , The cabinets ...
(Date:9/18/2014)... September 18, 2014 Demand for competency-based ... seek more efficient routes to job placement and employers ... not have come at a better time as the ... supply. , Working in collaboration with employers, career educators ... approach to CBE implementation and direct assessment ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Court Orders C.R. Bard to Turn Over Relevant Documents to Plaintiffs, the Rottenstein Law Group LLP Reports 2Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 2Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 3Health News:One Week Kitchens Taking Display to Bloomsburg Fair 2Health News:Wonderlic Unites Employers, Career Educators and Competency-Based Education Experts to Help Narrow Skills Gap 2
... has come out with a finding published in the journal ... substance like marijuana, alcohol, and cigarettes in solitude, tend to ... to have a harder time quitting, as opposed to those ... ,The results stem from a study spreading over ...
... genome is remarkably similar to that of humans' and may ... //University of Central Florida professor Cristina Calestani and several colleagues ... November issue of Science. ,Sea urchins are ... sea urchin has been used for many years as a ...
... reports success of rapid 3-D cell-growth technique that produces ... lab, it looks, contracts //and responds almost like natural ... goal of creating replacement parts for damaged human hearts, ... a spoonful of loose heart cells. ,This ...
... will do the rounds of rural areas as part of ... marginalized populations. // ,The government has released initial ... to set up mobile medical units in rural areas. ... been given under the National Rural Health Mission (NRHM) scheme ...
... Brain scans may help doctors predict schizophrenia, a mental disorder ... a new study. // ,Researchers at the University of ... a high risk of developing schizophrenia because two or more ... online edition of BBC News said. ,The researchers ...
... scheme 'Assistance for capacity Building', Ministry of Health ... maximum //of Rs. 1.50 crores or actual, whichever ... facilities of State Hospitals of towns/cities located on ... Department of Road Transport and Highways and Ministry ...
Cached Medicine News:Health News:Sea Urchin Genome Similar To Man And May Cure Diseases 2Health News:A New Rapid 3-D Cell-Growth Technique For Growing Heart Muscle 2Health News:A New Rapid 3-D Cell-Growth Technique For Growing Heart Muscle 3
... The OptiMumm™ smoke evacuator ... a complete smoke evacuation ... the AccuVac™ smoke evacuation ... system, and either the ...
... The De Mayo Knee Positioner reduces surgeon fatigue ... leg during surgery. The positioner's single locking ... and rotation. The same lever releases the ... of motion testing. The positioner is easily ...
... position for the seated patient and helps insure ... at 90 degrees to the leg. The foot ... Stockinette is pulled over the foot and tongue. ... routine fashion. The cast stand is slipped forward ...
CEMEX Fast Set is a solution for multiple indications and preferences. It is a self-contained delivery system in a convenient 70gm size....
Medicine Products: